Abstract
Three-dimensional (3D) printing was discovered in the 1980s, and many industries have embraced it, but the pharmaceutical industry is slow or reluctant to adopt it. Spiritam® is the first and only 3D-printed drug product approved by FDA in 2015. Since then, the FDA has not approved any 3D-printed drug product due to technical and regulatory issues. The 3D printing process cannot compete with well-established and understood conventional processes for making solid dosage forms. However, pharmaceutical companies can utilize it where mass production is not required; rather, consistency, precision, and accuracy in quality are paramount. There are many 3D printing technologies available, and not all of them are amenable to pharmaceutical manufacturing. Each 3D technology has certain prerequisites in terms of material that it can handle. Some of the pertinent technical and regulatory issues are as follows: Current Good Manufacturing Practice, in-process tests and process control, and cleaning validation. Other promising area of 3D printing use is printing medications for patients with special needs in a hospital and/or pharmacy setting with minimum regulatory oversight. This technology provides a novel opportunity for in-hospital compounding of necessary medicines to support patient-specific medications. However, aspects of the manufacturing challenges and quality control considerations associated with the varying formulation and processing methods need to be fully understood before 3D printing can emerge as a therapeutic tool. With these points in mind, this review paper focuses on 3D technologies amenable for pharmaceutical manufacturing, excipient requirement, process understanding, and technical and regulatory challenges.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.References
3D printing industry. The free beginner’s guide. Access on Oct 27, 2017. https://3dprintingindustry.com/3d-printing-basics-free-beginners-guide#02-history.
Norman J, Madurawe RD, Moore CM, Khan MA, Khairuzzaman A. A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Adv Drug Deliv Rev. 2017;108:39–50.
McCue TJ. Wohlers Report: 3D printing industry surpassed $5.1 billion. Forbes. 2016. https://www.forbes.com/sites/tjmccue/2016/04/25/wohlers-report-2016-3d-printer-industry-surpassed-5-1-billion/#3cff22c719a0. April 25, 2016.
As 3-D printing emerges from prototyping to assume a role in mass manufacturing and production, the industry must adapt, PWC 30, 2017. Access on Oct 27, 2017. http://usblogs.pwc.com/emerging-technology/5-ways-3d-printing-revolutionizes-manufacturing/
Hollander J, Natalja G, Harri J, Mohammad K, Ari R, Ermei M, et al. Three-dimensional printed PCL-based implantable prototypes of medical devices for controlled drug delivery. J Pharm Sci. 2016;105:2665–76.
Chung P, Heller JA, Etemadi M, Ottoson PE, Liu JA, Rand L, et al. Rapid and low-cost prototyping of medical devices using 3D printed molds for liquid injection molding. J Vis Exp. 2014;100:3386–95.
Water JJ, Bohr A, Boetker J, Aho J, Sandler N, Nielsen HM, et al. Three dimensional printing of drug-eluting implants: preparation of an antibacterial polylactide feedstock material. J Pharm Sci. 2015;104:1099–107.
Boland T, Xu T, Damon B, Cui X. Application of inkjet printing to tissue engineering. Biotechnol J. 2006;1(9):910–7.
Pati F, Shim JH, Lee JS, Cho DW. 3D printing of cell-laden constructs for heterogeneous tissue regeneration. MFGLET. 2013;1(1):49–53.
Korte C, Quodbach J. Formulation development and process analysis of drug-loaded filaments manufactured via hot-melt extrusion for 3D-printing of medicines. Pharm Dev Technol. 2018;25:1–33.
Yu DG, Branford-White WC, Yang YC, Zhu LM, Welbeck EW, Yang XL. A novel fast disintegrating tablet fabricated by three-dimensional printing. Drug Dev Ind Pharm. 2009;35(12):1530–6.
Goyanes A, Buanz AB, Hatton GB, Gaisford S, Basit AW. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets. Eur J Pharm Biopharm. 2015;89:157–62.
Brennan Z, FDA to issue more guidance on 3D printing. Regulatory Affairs Professionals Society, Dec 2016. Access on Oct 27, 2017. http://www.raps.org/Regulatory-Focus/News/2016/12/21/26472/FDA-to-Issue-More-Guidance-on-3D-Printing/.
First FDA-approved medicine manufactured using 3D printing technology now available. Aprecia Pharmaceuticals, March 22, 2016. Access on Oct 27, 2017. https://www.aprecia.com/pdf/ApreciaSPRITAMLaunchPressRelease__FINAL.PDF.
Goole J, Amighi K. 3D printing in pharmaceutics: a new tool for designing customized drug delivery systems. Int J Pharm. 2016;499(1–2):376–94.
Alhnan MA, Okwuosa TC, Sadia M, Wan KW, Ahmed W, Arafat B. Emergence of 3D printed dosage forms: opportunities and challenges. Pharm Res. 2016;33(8):1817–32.
Ventola CL. Medical applications for 3D printing: current and projected uses. P T. 2014;39:704–11.
ISO/ASTM52900-15. Standard terminology for additive manufacturing—general principles—terminology. West Conshohocken, PA: ASTM International; 2015.
Chai X, Chai H, Wang X, Yang J, Li J, Zhao Y, et al. Fused deposition modeling (FDM) 3D printed tablets for intragastric floating delivery of domperidone. Sci Rep. 2017;7(1):282.
Lara-Padilla H, Mendoza-Buenrostro C, Cardenas D, Rodriguez-Garcia A, Rodriguez CA. Influence of controlled cooling in bimodal scaffold fabrication using polymers with different melting temperatures. Materials (Basel). 2017;10(6):E640.
Columbus L. The state of 3D printing, 2017. Forbes, Oct 27, 2017. https://www.forbes.com/sites/louiscolumbus/2017/05/23/the-state-of-3d-printing-2017/#1cc435a457eb.
Chua CK, Leong KF, Lim CS. Rapid prototyping-Principles and applications. Edition third, World Scientific. 2003, p. 124.
Long J, Gholizadeh H, Lu J, Bunt C, Seyfoddin A. Application of fused deposition modelling (FDM) method of 3D printing in drug delivery. Curr Pharm Des. 2017;23:433–9.
Singamnenia S, Roychoudhury S, Diegela O, Huanga B. Modeling and evaluation of curved layer fused deposition. J Mat Proc Technol. 2012;212:27–35.
Jacobs PF. Rapid prototyping and manufacturing: Fundamentals of Stereolithography by Society of Manufacturing Engineers. New York:Mcgraw-Hill;1993.
Pucci JU, Christophe BR, Sisti JA, Connolly Jr ES. Three-dimensional printing: technologies, applications, and limitations in neurosurgery. Biotechnol Adv. 2017;35:521–9.
Favero CS, English JD, Cozad BE, Wirthlin JO, Short MM, Kasper FK. Effect of print layer height and printer type on the accuracy of 3-dimensional printed orthodontic models. Am J Orthod Dentofac Orthop. 2017;152:557–65.
Camardella LT, de Vasconcellos VO, Breuning H. Accuracy of printed dental models made with 2 prototype technologies and different designs of model bases. Am J Orthod Dentofac Orthop. 2017;151:1178–87.
Deckard C. Method and apparatus for producing parts by selective sintering. US Patent 5597589, 1989.
Bai J, Goodridge RD, Yuan S, Zhou K, Chua CK, Wei J. Thermal influence of CNT on the polyamide 12 nanocomposite for selective laser sintering. Molecules. 2015;20:19041–50.
Marro A, Bandukwala T, Mak W. Three-dimensional printing and medical imaging: a review of the methods and applications. Curr Probl Diagn Radiol. 2016;45:2–9.
Jakk. What is selective heat sintering (SHS), and how does it work? GoPrint3D April 2016. Access on Oct 27, 2017. https://www.goprint3d.co.uk/blog/selective-heat-sintering-shs-work/.
Binder jetting in 3D printing. Access on Oct 27, 2017. https://www.whiteclouds.com/3dpedia-index/binder-jetting-3d-printing.
Crawford M. 3D-printed drugs: what does the future hold? ASME 2015. Access on Oct 27, 2017. https://www.asme.org/engineering-topics/articles/manufacturing-design/3dprinted-drugs-does-future-hold.
Mancuso E, Alharbi N, Bretcanu OA, Marshall M, Birch MA, McCaskie AW, et al. Three-dimensional printing of porous load-bearing bioceramic scaffolds. Proc Inst Mech Eng H. 2017;231:575–85.
Sheydaeian E, Vlasea M, Woo A, Pilliar R, Hu E, Toyserkani E. Effect of glycerol concentrations on the mechanical properties of additive manufactured porous calcium polyphosphate structures for bone substitute applications. J Biomed Mater Res B Appl Biomater. 2017;105:828–35.
Chia HN, Wu BM. Recent advances in 3D printing of biomaterials. J Bio Eng. 2015;9:4.
FDA inactive ingredient database. Access on Oct 27, 2017. https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm.
FDA data of generally recognized as safe. Access on Oct 27, 2017. https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm. https://www.fda.gov/food/ingredientspackaginglabeling/gras/.
3D printer filament comparison guide. Accessed on Oct 27, 2017. https://www.matterhackers.com/3d-printer-filament-compare.
Hagan SA, Coombes AGA, Garnett MC, Dunn SE, Davies MC, Illum L, et al. Polylactide-poly(ethylene glycol) copolymers as drug delivery systems. Characterization of water dispersible micelle-forming systems. Langmuir. 1996;12:2153–61.
Okwuosa TC, Stefaniak D, Arafat B, Isreb A, Wan KW, Alhnan MA. A lower temperature FDM 3D printing for the manufacture of patient-specific immediate release tablets. Pharm Res. 2016;33(11):2704–12.
Pietrzak K, Isreb A, Alhnan MA. A flexible-dose dispenser for immediate and extended release 3D printed tablets. Eur J Pharm Biopharm. 2015;96:380–7.
Beck RCR, Chaves PS, Goyanes A, Vukosavljevic B, Buanz A, Windbergs M, et al. 3D printed tablets loaded with polymeric nanocapsules: an innovative approach to produce customized drug delivery systems. Int J Pharm. 2017;528:268–79.
Sadia M, Sośnicka A, Arafat B, Isreb A, Ahmed W, Kelarakis A, et al. Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets. Int J Pharm. 2016;513(1–2):659–68.
Sadia M, Arafat B, Ahmed W, Forbes RT, Alhnan MA. Channelled tablets: an innovative approach to accelerating drug release from 3D printed tablets. J Control Release. 2018;269:355–63.
Kim J, McBride S, Tellis B, Alvarez-Urena P, Song Y-H, Dean DD, et al. Rapid-prototyped PLGA/β-TCP/hydroxyapatite nanocomposite scaffolds in a rabbit femoral defect model. Biofabrication. 2012;4:025003.
Zhang J, Feng X, Patil H, Tiwari RV, Repka MA. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets. Int J Pharm. 2017;519:186–97.
Zein I, Hutmacher DW, Tan KC, Teoh SH. Fused deposition modeling of novel scaffold architectures for tissue engineering applications. Biomaterials. 2002;23:1169–85.
Hutmacher DW, Schantz T, Zein I, Ng KW, Teoh SH, Tan KC. Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling. J Biomed Mater Res. 2001;55:203–16.
Guo T, Holzberg TR, Lim CG, Gao F, Gargava A, Trachtenberg JE, et al. 3D printing PLGA: a quantitative examination of the effects of polymer composition and printing parameters on print resolution. Biofabrication. 2017;9(2):024101.
Tagami T, Fukushige K, Ogawa E, Hayashi N, Ozeki T. 3D printing factors important for the fabrication of polyvinylalcohol filament-based tablets. Biol Pharm Bull. 2017;40:357–64.
Goyanes A, Buanz AB, Basit AW, Gaisford S. Fused-filament 3D printing (3DP) for fabrication of tablets. Int J Pharm. 2014;476:88–92.
Melocchi A, Loreti G, Cuto MDD, Maroni A, Gazzaniga A, Zema L. Evaluation of hot-melt extrusion and injection molding for continuous manufacturing of immediate-release tablets. J Pharm Sci. 2015;104:1971–80.
Melocchi A, Parietti F, Maroni A, Foppoli A, Gazzaniga A, Zema L. Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling. Int J Pharm. 2016;509(1–2):255–63.
Okwuosa TC, Pereira BC, Arafat B, Cieszynska M, Isreb A, Alhnan MA. Fabricating a shell-core delayed release tablet using dual FDM 3D printing for patient-centred therapy. Pharm Res. 2017;34(2):427–37.
Huang S, O’Donnell KP, Delpon de Vaux SM, O'Brien J, Stutzman J, Williams RO 3rd. Processing thermally labile drugs by hot-melt extrusion: the lesson with gliclazide. Eur J Pharm Biopharm. 2017;119:56–67.
Rahman Z, Siddiqui A, Gupta A, Khan MA. Regulatory considerations in development of amorphous solid dispersions. In: Shah N, Sandhu H, Choi DS, Chokshi H, Malick WA, editors. Amorphous solid dispersions-regulatory considerations in development of amorphous solid dispersions. New York: Springer; 2014. p. 545–63. ISBN: 978-1-4939-1597-2.
Stereolithography (SLA), Formlabs Access on Oct 27, 2017. https://formlabs.com/resources/stereolithography-3d-printing/.
Clark EA, Alexander MR, Irvine DJ, Roberts CJ, Wallace MJ, Sharpe S, et al. 3D printing of tablets using inkjet with UV photoinitiation. Int J Pharm. 2017;529:523–30.
He Y, Tuck CJ, Prina E, Kilsby S, Christie SDR, Edmondson S, et al. A new photocrosslinkable polycaprolactone-based ink for three-dimensional inkjet printing. J Biomed Mater Res B Appl Biomater. 2017;105(6):1645–57.
Wang J, Goyanes A, Gaisford S, Basit AW. Stereolithographic (SLA) 3D printing of oral modified-release dosage forms. Int J Pharm. 2016;503:207–12.
Neiman JA, Raman R, Chan V, Rhoads MG, Raredon MS, Velazquez JJ, et al. Photopatterning of hydrogel scaffolds coupled to filter materials using stereolithography for perfused 3D culture of hepatocytes. Biotechnol Bioeng. 2015;112:777–87.
Kim MS, Son JG, Lee HJ, Hwang H, Choi CH, Kim GH. Highly porous 3D nanofibrous scaffolds processed with an electrospinning/laser process. Curr Appl Phys. 2014;14:1–7.
Lee D-H, Mai HN, Yang JC, Kwon TY. The effect of 4,4′-bis(N,N-diethylamino) benzophenone on the degree of conversion in liquid photopolymer for dental 3D printing. J Adv Prosthodont. 2015;7:386–91.
Manapat JZ, Mangadlao JD, Tiu BD, Tritchler GC, Advincula RC. High-strength stereolithographic 3D printed nanocomposites: graphene oxide metastability. ACS Appl Mater Interfaces. 2017;22(9):10085–93.
Shirazi SFS, Gharehkhani S, Mehrali M, Yarmand H, Metselaar HSC, Kadr NA, et al. A review on powder-based additive manufacturing for tissue engineering: selective laser sintering and inkjet 3D printing. Sci Technol Adv Mater. 2015;16:033502.
Duan B, Wang M, Zhou WY, Cheung WL, Li ZY, Lu WW. Three-dimensional nanocomposite scaffolds fabricated via selective laser sintering for bone tissue engineering. Acta Biomater. 2010;6:4495–505.
Lohfeld S, Tyndyk M, Cahill S, Flaherty N, Barron V, McHugh P. A method to fabricate small features on scaffolds for tissue engineering via selective laser sintering. J Biomed Sci Eng. 2010;3:138–47.
Yeong WY, Sudarmadji N, Yu HY, Chua CK, Leong KF, Venkatraman SS, et al. Porous polycaprolactone scaffold for cardiac tissue engineering fabricated by selective laser sintering. Acta Biomater. 2010;6:2028–34.
Chua C, Leong K, Tan K, Wiria F, Cheah C. Development of tissue scaffolds using selective laser sintering of polyvinyl alcohol/hydroxyapatite biocomposite for craniofacial and joint defects. J Mater Sci Mater Med. 2004;15:1113–21.
Fina F, Goyanes A, Gaisford S, Basit AW. Selective laser sintering (SLS) 3D printing of medicines. Int J Pharm. 2017;529:285–93.
Thermoplastics with Polyox™ resins. Access on Oct 23, 2017. http://msdssearch.dow.com/PublishedLiteratureDOWCOM/dh_003a/0901b8038003a657.pdf?filepath=/pdfs/noreg/326-00039.pdf&fromPage=GetDoc.
Rahman Z, Zidan AS, Korang-Yeboah M, Yang Y, Siddiqui A, Shakleya D, et al. Effects of excipients and curing process on the abuse deterrent properties of directly compressed tablets. Int J Pharm. 2017;517:303–11.
Rahman Z, Yang Y, Korang-Yeboah M, Siddiqui A, Xu X, Ashraf M, et al. Assessing impact of formulation and process variables on in-vitro performance of directly compressed abuse deterrent formulations. Int J Pharm. 2016;502:138–50.
Yu DG, Shen XX, Branford-White C, Zhu LM, White K, Yang XL. Novel oral fast-disintegrating drug delivery devices with predefined inner structure fabricated by three-dimensional printing. J Pharm Pharmacol. 2009;61(3):323–9.
Katstra WE, Palazzolo RD, Rowe CW, Giritlioglu B, Teung P, Cima MJ. Oral dosage forms fabricated by three dimensional printing. J Control Release. 2000;66(1):1–9.
Rowe CW, Katstra WE, Palazzolo RD, Giritlioglu B, Teung P, Cima MJ. Multimechanism oral dosage forms fabricated by three dimensional printing. J Control Release. 2000;66(1):11–7.
Rahman Z, Korang-Yeboah M, Siddiqui A, Mohammad A, Khan MA. Understanding effect of formulation and manufacturing variables on the critical quality attributes of warfarin sodium product. Int J Pharm. 2015;495:19–30.
Calvert P. Inkjet printing for materials and devices. Chem Mat. 2001;13:3299–305.
Wood V, Panzer MJ, Chen J, Bradley MS, Halpert JE, Bawendi MG, et al. Inkjet-printed quantum dot-polymer composites for full-color ac-driven displays. Adv Mater. 2009;21:2151–5.
Rahmati S, Shirazi F, Baghayeri H. Perusing piezoelectric head performance in a new 3-D printing design. Tsinghua Sci Technol. 2009;14:24–8.
Peters F, Groisman D, Davids R, Hänel T, Dürr H, Klein M. Comparative study of patient individual implants from β-tricalcium phosphate made by different techniques based on CT data. Mater Werkst. 2006;37:457–61.
Carson JW, Pittenger BH. Bulk properties of powder. In Powder Metal Technologies and applications: Edited by Lee PW, Trudel Y, Iacocca R, German RM, Ferguson BL, Eisen WB, Moyer K, Madan D, Sanderow H. ASM Handbook, Volume 1998;7;1998:287-301
Gold G, Duvall RN, Palermo BT, Slater JG. Powder flow studies III. Factors affecting the flow of lactose granules. J Pharm Sci. 1968;57:667–71.
Lanzetta M, Sachs E. Improved surface finish in 3D printing using bimodal powder distribution. Rapid Prototyp J. 2003;9:157–66.
Derby B. Inkjet printing ceramics: from drops to solid. J Eur Ceram Soc. 2011;31:2543–50.
Hogekamp S, Pohl M. Methods for characterizing wetting and dispersing of powder. Chem Ing Tech. 2004;76:385–90.
Pingali K, Mendez R, Lewis D, Michniak-Kohn B, Cuitino A, Muzzio F. Mixing order of glidant and lubricant—influence on powder and tablet properties. Int J Pharm. 2011;409:269–77.
Wu BM, Borland SW, Giordano RA, Cima LG, Sachs EM, Cima MJ. Solid free-form fabrication of drug delivery devices. J Control Release. 1996;40:77–87.
Kim SS, Utsunomiya H, Koski JA, Wu BM, Cima MJ, Sohn J, et al. Survival and function of hepatocytes on a novel three-dimensional synthetic biodegradable polymer scaffold with an intrinsic network of channels. Ann Surg. 1998;228:8–13.
Zeltinger J, Sherwood JK, Graham DA, Müeller R, Griffith LG. Effect of pore size and void fraction on cellular adhesion, proliferation, and matrix deposition. Tissue Eng. 2001;7:557–72.
Lam CXF, Mo XM, Teoh SH, Hutmacher DW. Scaffold development using 3D printing with a starch-based polymer. Mater Sci Eng C. 2002;20:49–56.
Seitz H, Rieder W, Irsen S, Leukers B, Tille C. Three-dimensional printing of porous ceramic scaffolds for bone tissue engineering. J Biomed Mater Res B Appl Biomater. 2005;74:782–8.
Rahman Z, Siddiqui A, Khan MA. Assessing the impact of nimodipine devitrification in the ternary cosolvent system through quality by design approach. Int J Pharm. 2013;455:113–23.
Krishnaiah YS, Xu X, Rahman Z, Yang Y, Katragadda U, Lionberger R, et al. Development of performance matrix for generic product equivalence of acyclovir topical creams. Int J Pharm. 2014;475:110–22.
Kolan KC, Leu MC, Hilmas GE, Velez M. Effect of material, process parameters, and simulated body fluids on mechanical properties of 13–93 bioactive glass porous constructs made by selective laser sintering. J Mech Behav Biomed Mater. 2012;13:14–24.
Salmoria GV, Klauss P, Paggi RA, Kanis LA, Lago A. Structure and mechanical properties of cellulose based scaffolds fabricated by selective laser sintering. Polym Test. 2009;28:648–52.
Feng P, Niu M, Gao C, Peng S, Shuai C. A novel two-step sintering for nano-hydroxyapatite scaffolds for bone tissue engineering. Sci Rep. 2014;4:5599.
Williams JM, Adewunmi A, Schek RM, Flanagan CL, Krebsbach PH, Feinberg SE, et al. Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering. Biomaterials. 2005;26:4817–27.
Goodridge RD, Tuck CJ, Hague RJM. Laser sintering of polyamides and other polymers. Prog Mater Sci. 2012;57:229–67.
Amorim FL, Lohrengel A, Neubert V, Higa CF, Czelusniak T. Selective laser sintering of Mo-CuNi composite to be used as EDM electrode. Rapid Prototyping J. 2014;20:59–68.
Savalani MM, Hao L, Dickens PM, Zhang Y, Tanner KE, Harris RA. The effects and interactions of fabrication parameters on the properties of selective laser sintered hydroxyapatite polyamide composite biomaterials. Rapid Prototyp J. 2012;18:16–27.
Sachdeva A, Singh S, Sharma V. Investigating surface roughness of parts produced by SLS process. Int J Adv Manuf Technol. 2013;64:1505–16.
Gu D, Shen Y. Effects of processing parameters on consolidation and microstructure of W–Cu components by DMLS J. Alloys Compd. 2009;473:107–15.
Wu BM, Cima MJ. Effects of solvent-particle interaction kinetics on microstructure formation during three-dimensional printing. Polymer Eng Sci. 1999;39:249–60.
Kumar AV, Dutta A, Fay JE. Electrophotographic printing of part and binder powders. Rapid Prototyping J. 2004;10:7–13.
Murphy SV, Atala A. 3D bioprinting of tissues and organs. Nat Biotechnol. 2014;32:773–85.
Noguera R, Lejeune M, Chartier T. 3D fine scale ceramic components formed by ink-jet prototyping process. J Eur Ceram Soc. 2005;25:2055–9.
Rahmati S, Shirazi S, Baghayeri H. Piezo-electric head application in a new 3D printing design. Rapid Prototyping J. 2009;15:187–91.
Xu T, Jin J, Gregory C, Hickman JJ, Boland T. Inkjet printing of viable mammalian cells. Biomaterials. 2005;26:93–9.
Kim JD, Choi JS, Kim BS, Choi YC, Cho YW. Piezoelectric inkjet printing of polymers: stem cell patterning on polymer substrates. Polymer. 2010;51:2147–54.
Rahman Z, Siddiqui A, Khan MA. Characterization of a nonribosomal peptide antibiotic solid dispersion formulation by process analytical technologies sensors. J Pharm Sci. 2013;102:4337–46.
Rahman Z, Mohammad A, Siddiqui A, Khan MA. Comparison of univariate and multivariate models of 13C SSNMR and XRPD techniques for quantification of nimodipine polymorphs. AAPS PharmSciTech. 2015;16(6):1368–76.
Rao Pk LJ, Roberson D, Kong Z, Williams C. Online real-time quality monitoring in additive manufacturing processes using heterogeneous sensors. J Manuf Sci Eng. 2015;137:61007.
Rieder H, Dillhoffer A, Spies M, Bamberg J, Hess T. Online monitoring of additive manufacturing processes using ultrasound. 11th European Conference on Non-Destructive Testing. 2014;6-10.
Kleszczynski S, Jacobsmuhlen JZ, Sehrt JT, Witt G. Error detection in laser beam melting systems by high-resolution imaging. Proceedings of the Twenty Third Annual International Solid Freeform Fabrication Symposium. 2012. Accessed on Oct 27, 2017. http://sffsymposium.engr.utexas.edu/Manuscripts/2012/2012-74-Kleszczynski.pdf.
Berumen S, Bechmann F, Lindner S, Kruth JP, Craeghs T. Quality control of laser- and powder bed-based additive manufacturing (AM) technologies. Phys Procedia. 2010;5:617–22.
Wing I, Gorham R, Sniderman B. 3D opportunity for quality assurance and parts qualification. Deloitte Insights Nov 18, 2015. Access on Oct 27, 2017. https://dupress.deloitte.com/dup-us-en/focus/3d-opportunity/3d-printing-quality-assurance-in-manufacturing.html.
Rahman Z, Mohammad A, Akhtar S, Siddiqui A, Korang-Yeboah M, Khan MA. Chemometric model development and comparison of Raman and (13)C solid-state nuclear magnetic resonance-chemometric methods for quantification of crystalline/amorphous warfarin sodium fraction in the formulations. J Pharm Sci. 2015;104(8):2550–8.
Siddiqui A, Rahman Z, Sayeed VA, Khan MA. Chemometric evaluation of near infrared, Fourier transform infrared, and Raman spectroscopic models for the prediction of nimodipine polymorphs. J Pharm Sci. 2013;102:4024–35.
FDA: Q4B evaluation and recommendation of pharmacopeial texts for use in the ICH regions, annex 9(R1) tablet friability general chapter guidance for industry, 2017.
FDA: Q4B evaluation and recommendation of pharmacopeial texts for use in the ICH regions, annex 5(R1) disintegration test general chapter guidance for industry, 2017.
Alafaghani A, Qattawi A, Ablat MA. Design consideration for additive manufacturing: fused deposition modelling. Open J Appl Sci. 2017;7:219–318.
Print troubleshooting pictorial guide. Access on Oct 27, 2017. http://reprap.org/wiki/Print_Troubleshooting_Pictorial_Guide.
3D printing troubleshooting: 33 common 3D printing problems. Access on Oct 27, 2017. https://all3dp.com/1/common-3d-printing-problems-troubleshooting-3d-printer-issues/.
Print quality troubleshooting guide. Access on Oct 27, 2017. https://www.simplify3d.com/support/print-quality-troubleshooting/.
Hudson B. How to design parts for FDM 3D printing. Access on Oct 27, 2017. https://www.3dhubs.com/knowledge-base/how-design-parts-fdm-3d-printing.
Zhang B, Li Y, Bai Q. Defect formation mechanisms in selective laser melting: a review. Chin J Mech Eng. 2017;30:515–27.
Wang RJ, Wang L, Zhao L, Liu Z. Influence of process parameters on part shrinkage in SLS. Int J Adv Manuf Technol. 2007;33:498–504.
Farzadi A, Solati-Hashjin M, Asadi-Eydivand M, Abu Osman NA. Effect of layer thickness and printing orientation on mechanical properties and dimensional accuracy of 3D printed porous samples for bone tissue engineering. PLoS One. 2014;9:e108252.
Code of Federal Regulations Title 21 food and drugs, Chapter I—Food and Drug Administration, Subchapter C Drugs: general, Part 211 current good manufacturing practice for finished pharmaceuticals, 2017.
Siew A. Increasing tablet production with multi-tip tooling. PharmaTech June 2015. Access on Oct 27, 2017. http://www.pharmtech.com/increasing-tablet-production-multi-tip-tooling.
McHugh KJ, Nguyen TD, Linehan AR, Yang D, Behrens AM, Rose S, et al. Fabrication of fillable microparticles and other complex 3D microstructures. Science. 2017;357:2238–1142.
Stephens B, Azimi P, El Orch Z, Ramos T. Ultrafine particle emissions from desktop 3D printers. Atmos Environ. 2013;79:334–9.
Yi HG, Choi YJ, Kang KS, Hong JM, Pati RG, Park MN, et al. A 3D-printed local drug delivery patch for pancreatic cancer growth suppression. J Control Release. 2016;238:231–41.
Tappa K, Jammalamadaka U, Ballard DH, Bruno T, Israel MR, Vemula H, et al. Medication eluting devices for the field of OBGYN (MEDOBGYN): 3D printed biodegradable hormone eluting constructs, a proof of concept study. PLoS One. 2017;12:e0182929.
Schell KH. Compliance issues and extemporaneous preparation of medications for pediatric patients. J Pharm Technol. 1992;8:158–61.
Gudeman J, Jozwiakowski M, Chollet J, Randell M. Potential risks of pharmacy compounding. Drugs RD. 2013;13:1–8.
Khan MA. Some challenges in the development of pediatric formulations, FDA Pediatric advisory committee, 2012. Accessed on Oct 27, 2017 http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM289938.pdf.
Ivanovska V, Rademaker CMA, van Dijk L, Mantel-Teeuwisse AK. Pediatric drug formulations: a review of challenges and progress. Pediatrics 2014;134(2). Accessed on Oct 27, 2017 http://pediatrics.aappublications.org/content/134/2/361.
FDA guidance for industry-hospital and health system compounding under the federal food, drug and cosmetic act, 2016.
FDA guidance on pharmacy compounding of human drug products under section 503A of the federal food, drug and cosmetic act 2016.
Author information
Authors and Affiliations
Corresponding author
Additional information
Guest Editors: Marilyn N. Martinez and Adel Karara
Rights and permissions
About this article
Cite this article
Rahman, Z., Barakh Ali, S.F., Ozkan, T. et al. Additive Manufacturing with 3D Printing: Progress from Bench to Bedside. AAPS J 20, 101 (2018). https://doi.org/10.1208/s12248-018-0225-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1208/s12248-018-0225-6